EAC Meeting Program

Jointly Provided by the American College of Allergy, Asthma & Immunology (ACAAI)
and the Eastern Allergy Conference (EAC)

Accreditation

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American College of Allergy, Asthma & Immunology and the Eastern Allergy Conference. The American College of Allergy, Asthma and Immunology is accredited by the ACCME to provide continuing medical education for physicians.

Designation

The American College of Allergy, Asthma & Immunology (ACAAI) designates this live activity for a maximum of 14 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CBRN
The American College of Allergy, Asthma & Immunology (ACAAI) is a provider, approved by the California Board of Registered Nursing, Provider Number CEP17239, for 14 contact hours.

This activity is supported by educational grants from commercial interests. Complete information will be provided to participants prior to the activity.

In compliance with the Americans with Disabilities Act, EAC requests that any participant in need of accommodations submit a written request to EAC well in advance.

Please contact Ginny Loiselle at 401-223-1309 or GinnyLoiselle@easternallergyconference.org.

2022 Program

Thursday, June 2, 2022

4:15 – 4:55 The Long Covid Syndrome: A conundrum for the Allergist/Immunologist

Joseph Bellanti, MD

4:55 – 5:35 What’s new in AIT?

Hal Nelson, MD

5:35 – 6:15 What’s new in EGIDs

Princess Ogbogu, MD

6:15 – 6:30 Panel Discussion: Q & A

Friday, June 3, 2022

7:45 – 8:15 HAE: Managing the difficult to treat patient

Paula Busse, MD

8:15 – 8:45 Bacterial lysate therapy for patients with allergic diseases

Hal Nelson, MD

8:45 – 8:55 Panel Discussion: Q & A

8:55 – 10:15 PBL: A 18-year-old woman with a chronic pruritic rash

Ray Davis, MD, Don Bukstein, MD, Russell Settipane, MD,

Dana Wallace, MD, Michael Blaiss, MD

10:15 – 11:00 Coffee Break: Visit Exhibits and Posters

11:00 – 11:15 PBL wrap up

Dana Wallace, MD

11:15 – 11:40 Treatment options for moderate to severe atopic dermatitis

Dana Wallace, MD

11:40 – 12:05 Current and future management of CSU/CIndU

Shyam Joshi, MD

12:05 – 12:15 Panel Discussion: Q & A

1:15 – 1:45 New PIDDs and the evolving landscape of clinical immunology

Jordan Orange, MD

1:45 – 2:15 Autoinflammatory disease

Hal Hoffman, MD

2:15 – 2:30 Panel Discussion: Q & A

Saturday, June 4, 2022

7:45 – 8:15 PIDD: Where does genetic testing fit into the diagnostic evaluation

Jordan Orange, MD

8:15 – 8:45 CRSwNP management in the age of biologics

Shyam Joshi, MD

8:45 – 8:55 Panel Discussion: Q & A

8:55 – 10:15 PBL: A 46-year-old woman with dyspnea, wheeze and cough

Ray Davis, MD, Don Bukstein, MD, Russell Settipane, MD,

Dana Wallace, MD, Michael Blaiss, MD

10:15 – 11:00 Coffee Break: Visit Exhibits and Posters

11:00 – 11:15 PBL wrap up

Russell Settipane, MD

11:15 – 12:05 Debate: Targeted therapies for specific asthma phenotypes or not?

Pro – Mark Corbett, MD

Con – Michael Blaiss, MD

12:05 – 12:15 Panel Discussion: Q & A

1:15 – 1:45 Optimal management of the older adult with severe asthma

Paula Busse, MD

1:45 – 2:15 Severe pediatric asthma, biologics, and biomarkers

Andrew Liu, MD

2:15 – 2:30 Panel Discussion: Q & A

Sunday, June 5, 2022

8:15 – 8:45 Eosinophilia: Differential diagnosis, evaluation, and management

Princess Ogbogu, MD

8:45 – 9:15 Update on cold induced syndromes for the allergist

Hal Hoffman, MD

9:15 – 9:45 Non-IgE-mediated drug allergies

Shyam Joshi, MD

9:45 – 10:00 Panel Discussion: Q & A